SCHEMBL7532767

SCHEMBL7532767

COc1ccc2[nH]c(C(=O)NN)c(-c3ccccc3)c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.68
ALDH1A1 P00352 6/20 0.68
GAA P10253 3/20 0.68
MAPT P10636 3/20 0.68
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA4 P22748 1/20 0.64
CA6 P23280 1/20 0.64
CA5A P35218 1/20 0.64
CA7 P43166 1/20 0.64
CA9 Q16790 1/20 0.64
CA14 Q9ULX7 1/20 0.64
CA5B Q9Y2D0 1/20 0.64
KMT2A Q03164 6/20 0.63
MEN1 O00255 5/20 0.63
HPGD P15428 4/20 0.57
LMNA P02545 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6842213 0.84 MEN1 (0.73) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL4592574 0.82 ALDH1A1 (0.73) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL7560818 0.81 MAPT (0.80) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL7560814 0.81 MAPT (0.80) KDM4EALDH1A1GAAMAPTKMT2A
SCHEMBL7560999 0.81 ALDH1A1 (1.00) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL7675754 0.81 MAP2 (0.74) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL5159252 0.81 KDM4E (0.63) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL7566685 0.80 GAA (1.00) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL1724013 0.78 CA1 (1.00) KDM4EALDH1A1GAAMAPTCA12
SCHEMBL7558641 0.77 MAPT (0.89) KDM4EALDH1A1GAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed
US-6323228-B1 INHIBITING ANGIOGENESIS IN A MAMMAL IN RECOGNIZED NEED OF SUCH TREATMENT COMPRISING ADMINISTERING TO THE MAMMAL WITH INDOLE SUBSTITUTED WITH HYDRAZIDES ABBOTT LABORATORIES 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 KDM4E 1608/4885ALDH1A1 98/4885GAA 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.